Scientists harvest valuable protein and fiber from spent brewery grain

The brewing of beer produces great quantities of leftover grain, which often ends up being processed into cattle feed. Scientists have developed a new method of extracting the protein and fiber from that waste, however, for use by humans.Continue Readi… Continue reading Scientists harvest valuable protein and fiber from spent brewery grain

Scientists produce artificial mucus with antimicrobial properties

It may be a bit gross, but mucus plays a key role in our bodies. Now, an MIT team has managed to create an artificial version of the stuff, and shown that it’s an effective antimicrobial – even more so than real mucus.Continue ReadingCategory: ScienceT… Continue reading Scientists produce artificial mucus with antimicrobial properties

Protein discovery promises powerful new muscle regrowth treatments

Although muscle stem cells are able to grow and repair torn muscle tissue after we sustain an injury, they become less effective as we age. Now researchers at the Australian Regenerative Medicine Institute at Monash University have discovered a novel p… Continue reading Protein discovery promises powerful new muscle regrowth treatments

Alzheimer’s scientists uncover “seeding” process of toxic protein tangles

Tau tangles (blue) can build up inside neurons, and are implicated in the formation of Alzheimer's

Researchers in Australia and China have shed new light on the murky origins of neurodegenerative diseases like Alzheimer’s, which could eventually lead to new treatments. The team uncovered a mechanism for how toxic tangles of tau proteins leak into healthy brain cells.

Continue Reading

Category: Medical, Science

Tags: , , , , , , , ,

Continue reading Alzheimer’s scientists uncover “seeding” process of toxic protein tangles

Scientists bypass “undruggable” cancer proteins to shrink tumors in mice

Researchers at Vanderbilt University have discovered how to effectively switch off a gene that drives the growth of cancer. The gene, known as Myc, has long been a target but was considered “undruggable” – so the team instead shut down a protein that i… Continue reading Scientists bypass “undruggable” cancer proteins to shrink tumors in mice

World-first biomarker test can predict depression and bipolar disorder

Australian scientists have developed and validated a world-first test that is claimed to accurately measure levels of a brain protein known to be associated with depression and bipolar disorder. The new research suggests this test could offer doctors a… Continue reading World-first biomarker test can predict depression and bipolar disorder

World-first biomarker test can predict depression and bipolar disorder

Australian scientists have developed and validated a world-first test that is claimed to accurately measure levels of a brain protein known to be associated with depression and bipolar disorder. The new research suggests this test could offer doctors a… Continue reading World-first biomarker test can predict depression and bipolar disorder

Experimental Alzheimer’s drug delivers promising Phase 2 trial results

Preliminary Phase 2 trial results of donanemab suggest the drug slows cognitive decline compared to placebo

Although yet to be published in a peer-reviewed journal, pharmaceutical company Eli Lilly has announced promising results from one of its Phase 2 human trials testing an experimental Alzheimer’s disease drug designed to slow cognitive decline.

Continue Reading

Category: Science

Tags: , , , , ,

Continue reading Experimental Alzheimer’s drug delivers promising Phase 2 trial results

Molecular “off” switch keeps cancer immunotherapy from turning deadly

One of the most promising cancer treatments is CAR T cell immunotherapy, where the body’s natural tumor-hunting cells are supercharged – but it can backfire with potentially deadly results. Now, scientists have engineered these immune cells to have off… Continue reading Molecular “off” switch keeps cancer immunotherapy from turning deadly

Artificial enzyme could slow Parkinson’s by targeting protein clumps

Johns Hopkins scientists have created artificial enzymes that may slow the progression of Parkinson's disease by halting the spread of pathogenic protein clumps

Neurodegenerative diseases like Parkinson’s are characterized by clumps of misfolded proteins accumulating and killing brain cells. Now, researchers at Johns Hopkins have developed an artificial enzyme that may stop these clumps from spreading, providing a new potential treatment for Parkinson’s.

Continue Reading

Category: Medical, Science

Tags: , , , , ,

Continue reading Artificial enzyme could slow Parkinson’s by targeting protein clumps